Showing results 1 to 2 of 2
| Title | Author(s) | Issue Date | |
|---|---|---|---|
| 2019 | |||
Neratinib in the extended adjuvant treatment of patients from Asia with early-stage HER2+ breast cancer after trastuzumab-based therapy: exploratory analyses from the phase III ExteNET trial Proceeding/Conference:San Antonio Breast Cancer Congress (SABCS) | 2017 |